US plans to resume production of highly radioactive plutonium-238

THE US reportedly plans to resume production of plutonium-238, a substance so radioactive that a speck can cause cancer.

US plans to resume production of highly radioactive plutonium-238

The material, used as a power source, would primarily be used for secret national security missions, according to people involved in the project who declined to give details, the New York Times said.

In the past, nuclear batteries made from plutonium-238 were used to power satellites, planetary probes and spy devices, it said.

“Plutonium-238 is hundreds of times more radioactive than the kind of plutonium used in nuclear arms, plutonium-239,” the daily said.

The plan, to be submitted to US Congress some time in 2006, calls for the manufacture of 150 kilograms over 30 years, starting in 2012. The programme would cost $1.5 billion and generate more than 50,000 drums of hazardous and radioactive waste, according to The Times.

Production would take place at the sprawling Idaho National Laboratory, raising the ire of environmentalists because of its proximity to prized wilderness areas such as Grand Teton National Park and Yellowstone National Park.

The US last manufactured plutonium-238 during the Cold War in the 1980s, and currently relies on Russian imports, which cannot be used for military purposes, and on its own stockpiles, which are fast depleting.

Plutonium is an artificially produced element created by bombarding uranium-238 with deuterons. Two of plutonium’s several isotopes are used outside of basic research - plutonium 239, which forms the core of nuclear warheads and some nuclear reactors, and plutonium-238, which has been used primarily on space probes too distant from the sun to use solar power. The accidental destruction of a satellite powered by plutonium-238 in 1964 spread radioactivity around the globe, The Times said.

Experts say newer nuclear batteries are far safer and the risk of human exposure is “extraordinarily low,” according to the daily.

x

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited